Pages that link to "Q37614638"
Jump to navigation
Jump to search
The following pages link to Novel targeted therapies for autoimmunity (Q37614638):
Displaying 16 items.
- Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases (Q26823714) (← links)
- Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics (Q26849243) (← links)
- Solving the puzzle of autoimmunity: critical questions (Q28084677) (← links)
- Restoring the balance: immunotherapeutic combinations for autoimmune disease (Q33555986) (← links)
- Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies (Q33895804) (← links)
- Cytokine modulators in the treatment of sarcoidosis (Q34190083) (← links)
- Cytokines as therapeutic targets in SLE. (Q37741799) (← links)
- Emerging small molecule and biological therapeutic approaches for the treatment of autoimmunity (Q37813704) (← links)
- CD28 co-signaling in the adaptive immune response. (Q37864546) (← links)
- Autologous haemopoietic stem cell transplantation for autoimmune diseases (Q37879139) (← links)
- Emerging immunological targets in inflammatory bowel disease (Q37946021) (← links)
- Cellular and molecular mechanisms of autoimmune disease (Q37959331) (← links)
- B1 cells promote pancreas infiltration by autoreactive T cells. (Q38708625) (← links)
- Orientation-specific attachment of polymeric microtubes on cell surfaces (Q39107347) (← links)
- Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling (Q42238004) (← links)
- Conference Scene: Highlights of the 7th Autoimmunity Congress (Q85100586) (← links)